Literature DB >> 33494426

Control of Capsid Transformations during Reovirus Entry.

Stephanie L Gummersheimer1, Anthony J Snyder1, Pranav Danthi1.   

Abstract

Mammalian orthoreovirus (reovirus), a dsRNA virus with a multilayered capsid, serves as a model system for studying the entry of similar viruses. The outermost layer of this capsid undergoes processing to generate a metastable intermediate. The metastable particle undergoes further remodeling to generate an entry-capable form that delivers the genome-containing inner capsid, or core, into the cytoplasm. In this review, we highlight capsid proteins and the intricacies of their interactions that control the stability of the capsid and consequently impact capsid structural changes that are prerequisites for entry. We also discuss a novel proviral role of host membranes in promoting capsid conformational transitions. Current knowledge gaps in the field that are ripe for future investigation are also outlined.

Entities:  

Keywords:  capsid; cell entry; reovirus

Year:  2021        PMID: 33494426     DOI: 10.3390/v13020153

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  3 in total

1.  Molecular Characterization of Outer Capsid Proteins VP5 and VP7 of Grass Carp Reovirus.

Authors:  Fuxian Zhang; Diangang Sun; Qin Fang
Journal:  Viruses       Date:  2022-05-12       Impact factor: 5.818

2.  Reovirus infection is regulated by NPC1 and endosomal cholesterol homeostasis.

Authors:  Paula Ortega-Gonzalez; Gwen Taylor; Rohit K Jangra; Raquel Tenorio; Isabel Fernandez de Castro; Bernardo A Mainou; Robert C Orchard; Craig B Wilen; Pamela H Brigleb; Jorna Sojati; Kartik Chandran; Martin Sachse; Cristina Risco; Terence S Dermody
Journal:  PLoS Pathog       Date:  2022-03-09       Impact factor: 6.823

3.  A CRISPR-Cas9 screen reveals a role for WD repeat-containing protein 81 (WDR81) in the entry of late penetrating viruses.

Authors:  Anthony J Snyder; Andrew T Abad; Pranav Danthi
Journal:  PLoS Pathog       Date:  2022-03-23       Impact factor: 6.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.